Elmiron® Prescription Drug Causing Vision Loss Lawsuit - Selinger Law Group
Breaking News - John Selinger Named 2022 NYCElmiron Prescription Drug Causing Vision Loss Lawsuit for the 13th time!

Elmiron® Prescription Drug Causing Vision Loss Lawsuit

Eye Pain Pills LgThe popular medication Elmiron, a prescription drug* used to treat bladder pain and discomfort associated with interstitial cystitis (IC), has been linked to serious eye damage. Elmiron users across the United States are claiming that the drug may cause a multitude of vision issues.

Users are claiming links between Elmiron and eye damage including:

  • Blurred vision
  • Difficulty reading
  • Distorted vision
  • Eye pain
  • Issues adjusting to darkness
  • Macular degeneration
  • Pigmentary maculopathy
  • Retinal maculopathy
  • Vision disturbances
  • Vision loss

Contact Us Today For A

FREE CASE EVALUATION









    One of our attorneys will review your case and respond to you within 24 hours.
    The information provided will not be shared with a third party.

    Elmiron Side Effects

    Numerous scientific studies have investigated the link between Elmiron and eye damage.

    Elmiron may be linked to the following diseases:

    • Macular degeneration
    • Pigmentary maculopathy
    • Retinal maculopathy

    Other Elmiron side effects may include:

    • Blurred vision
    • Difficulty reading
    • Distorted vision
    • Eye pain
    • Issues adjusting to darkness
    • Vision disturbances
    • Vision loss

    What Is Elmiron Used For?

    Elmiron is a FDA-approved oral drug for the treatment of bladder pain and discomfort brought on by interstitial cystitis is pentosan polysulfate sodium (Elmiron), which received FDA approval in 1996. (IC).

    IC, often known as "painful bladder syndrome," is an incurable chronic bladder illness.

    If you or a loved one used this IC medicine and got one of the aforementioned vision impairments, you may be qualified to bring a lawsuit against Elmiron.

    This website uses cookies to improve your experience. By using this website you agree to our Data Protection Policy.
    Read more